Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
$200,000
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 01/07/2026
This Notice of Funding Opportunity (NOFO) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that ...
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 01/07/2028
The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorb...
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 09/07/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as ...
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/14/2024
DUE: 09/28/2026
The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat centra...
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 09/28/2026
The purpose of this announcement is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disor...
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 10/25/2027
The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, sc...
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 10/25/2027
The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, s...
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/04/2024
UPDATED: 11/04/2024
DUE: 10/20/2027
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological ac...
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/04/2019
UPDATED: 10/12/2021
DUE: 10/12/2121
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Co...
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/01/2023
UPDATED: 11/13/2023
DUE: 08/18/2026
Reissue of PAR-18-541. The Blueprint Neurotherapeutics Network (BPN) encourages applications from small businesses seeking support to advance their small molecule drug discovery and development projec...